Lotus Reports January 2026 Revenue of NT$2,052 Million




Why Invest in Lotus?
At Lotus, we believe health is a right, not a privilege. With scientific rigor and operational precision, we tackle complex pharmaceutical challenges to expand the reach of trusted therapies, strengthen market leadership, and create lasting value worldwide. This is how we achieve Confidence in Every Dose and make high‑quality medicines accessible to all.
Financial Strength
We consistently deliver strong financial results, underpinned by a resilient core business and a two-pronged expansion strategy that drives profitability, market growth, and long-term shareholder value.
Diverse Product Portfolio
Our expanding portfolio includes complex generics with a focus on oncology, along with branded medicines, 505(b)(2) products, biosimilars, and NCEs—positioning Lotus as a strong, diversified global pharmaceutical company with multiple growth drivers.
Global Reach
With our growing presence in key markets worldwide, we are well-positioned to respond to the global demand for affordable healthcare solutions.
We Create Reliable, Long-Term Value









